MBIO News and Press, Mustang Bio Inc. From 05/14/21

WORCESTER, Mass., May 14, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, soli...

WORCESTER, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, soli...

Mustang Bio ([[MBIO]] -0.7%) has made available updated data from its ongoing Phase 1/2 clinical trial of MB-106 for patients with relapsed or refractory B-cell non-Hodgkin lymphoma (“NHL”).Newly released data were included in an abstract released ahead of the upcoming European ...

Mustang Bio (MBIO) announces that the FDA has accepted its Investigational New Drug ((IND)) application to initiate a Phase 1/2 study to assess the safety, tolerability and efficacy of MB-106, a CD20-targeted CAR T therapy for relapsed or refractory CD20+ B-cell non-Hodgkin lymphoma (B-NHL) a...

Alfi (ALF) +35%.SemiLEDs Corporation (LEDS) +19%.Protagenic Therapeutics (PTIX) +18%.Party City Holdco (PRTY) +12% on Q1 results.BioNTech SE (BNTX) +9% on Q1 results.Aptorum Group Limited (APM) +8%.VYNE Therapeutics (VYNE) +8%.Inovio Pharmaceuticals (INO) +8% on positive data f...

The Phase 1/2 multicenter study to assess the safety, tolerability and efficacy of MB-106 in patients with relapsed or refractory CD20+ B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia is expected to begin enrolling patients in the third quarter of this year WORCESTER,...

WORCESTER, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, so...

Are These The Top Biotech Penny Stocks to Buy in April? The pandemic has shined a large spotlight on biotech penny stocks over the past twelve months. Every time a company announced a new treatment or vaccine for Covid, traders quickly jumped to buy the trend. As a result, many breakout...

Does Your List Of Robinhood Penny Stocks Have These On It? Penny stocks are some of the highest risk investment classes in the stock market today. Yet they remain sought after by day traders and investors alike. The short-term prospects entail high-flying shares, turning a big profit qu...

Mustang Bio (MBIO): FY GAAP EPS of -$1.14 misses by $0.13.As of December 31, 2020, Mustang’s cash and cash equivalents and restricted cash totaled $98.8 million, compared to $62.4 million as of December 31, 2019, an increase of $36.4 million year-to-date.Shares +1.63%.Press Release F...